Parmax Pharma informs about board meeting outcome

12 Nov 2022 Evaluate

Parmax Pharma has informed about Outcome of the Board meeting and approval of Unaudited Financial statements for quarter and half year ended 30th September, 2022.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

48.94 4.24 (9.49%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...